Volume 7 Issue 1
Jun.  2023
Turn off MathJax
Article Contents
Ruoyang Zhang, Lina Cai, Zeeshan Ali, Jiuhai Wang, Enyong Fan, Mingyuan Wang, Minhui Wu, Zhiyang Li, Wenbiao Liang. A chemiluminescence based approach to nucleic acid testing to detect HBV, HCV, and HIV-1 in blood screening[J]. Blood&Genomics, 2023, 7(1): 34-42. doi: 10.46701/BG.2023012022032
Citation: Ruoyang Zhang, Lina Cai, Zeeshan Ali, Jiuhai Wang, Enyong Fan, Mingyuan Wang, Minhui Wu, Zhiyang Li, Wenbiao Liang. A chemiluminescence based approach to nucleic acid testing to detect HBV, HCV, and HIV-1 in blood screening[J]. Blood&Genomics, 2023, 7(1): 34-42. doi: 10.46701/BG.2023012022032

A chemiluminescence based approach to nucleic acid testing to detect HBV, HCV, and HIV-1 in blood screening

doi: 10.46701/BG.2023012022032
More Information
  • Corresponding author: Zhiyang Li, State Key Laboratory of Bioelectronics, Southeast University, Nanjing, Jiangsu 210096, China. E-mail: 1034109945@qq.com; Wenbiao Liang, Department of Transfusion Research, Jiangsu Province Blood Center, Nanjing, Jiangsu 210042, China. E-mail: wenbiaoliang@aliyun.com
  • Received Date: 2022-11-09
  • Rev Recd Date: 2022-12-22
  • Accepted Date: 2023-01-13
  • Available Online: 2023-04-10
  • Publish Date: 2023-06-30
  • Hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV) are life-threatening blood-borne infections that can be unintentionally transmitted in transfused blood products. Here, we optimized a method for detecting HBV, HCV, and HIV-1 in blood screening using magnetic nanoparticles (MNPs) and polymerase chain reaction (PCR)-chemiluminescence. Viral genomes were extracted from donated blood samples using MNPs. The isolated viral DNA and RNA were amplified in a one-step parallel reverse transcription-PCR (RT-PCR). HBV, HCV, and HIV-1 were detected using complementary nucleic acid probes and quantified using a chemiluminescent substrate. 10 422 donated blood samples were tested both with the above method and Roche Cobas TaqScreen MPX Test. The lengths of the amplified PCR products for HBV, HCV, and HIV-1 were 119 bp, 220 bp, and 174 bp, respectively, indicating that the extraction methods successfully separated high-quality viral genomes from the serum samples. The probes and reaction conditions used for the chemiluminescent detection of HBV, HCV, and HIV-1 genomes in unknown samples were empirically optimized. Of the 10 422 blood samples screened, 12 were HBV positive and 2 were HCV positive. These results were consistent with those of a parallel-controlled study using Roche Cobas TaqScreen MPX Test. The assay described here is fast, accurate, and sensitive for detecting HBV, HCV, and HIV, which runs in parallel and has broad implications for blood screening and epidemiological studies.


  • These authors contributed equally to this work.
  • loading
  • [1]
    Roth WK, Busch MP, Schuller A, et al. International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009[J]. Vox Sang, 2012, 102(1): 82−90. doi: 10.1111/j.1423-0410.2011.01506.x
    Sauvage V, Laperche S, Cheval J, et al. Viral metagenomics applied to blood donors and recipients at high risk for blood-borne infections[J]. Blood Transfus, 2016, 14(5): 400−407. doi: 10.2450/2016.0160-15
    Op de Coul ELM, Hogema BM, Sane J, et al. Evaluation of a fourth-generation avidity assay for recent HIV infections among men who have sex with men in Amsterdam[J]. J Med Microbiol, 2014, 63(8): 1116−1117. doi: 10.1099/jmm.0.074518-0
    Kwon JR, Won EJ, Jo HJ, et al. Serious adverse transfusion reactions reported in the national recipient-triggered trace back system in Korea (2006–2014)[J]. Ann Lab Med, 2016, 36(4): 335−341. doi: 10.3343/alm.2016.36.4.335
    Kiely P, Catton M, Brown D, et al. The potential complexity and need for caution when interpreting atypical human immunodeficiency virus reactivity in blood donors[J]. Blood Transfus, 2015, 13(4): 669−671. doi: 10.2450/2015.0034-15
    Saber HR, Tabatabaee SM, Abasian A, et al. Incidence and residual risk of HIV, HBV and HCV infections among blood donors in Tehran[J]. Indian J Hematol Blood Transfus, 2017, 33(3): 412−416. doi: 10.1007/s12288-016-0732-5
    Kumar R, Gupta S, Kaur A, et al. Individual donor-nucleic acid testing for human immunodeficiency virus-1, hepatitis C virus and hepatitis B virus and its role in blood safety[J]. Asian J Transfus Sci, 2015, 9(2): 199−202. doi: 10.4103/0973-6247.154250
    Rejali NA, Zuiter AM, Quackenbush JF, et al. Reverse transcriptase kinetics for one-step RT-PCR[J]. Anal Biochem, 2020, 601: 113768. doi: 10.1016/j.ab.2020.113768
    Ali Z, Wang J, Tang Y, et al. Simultaneous detection of multiple viruses based on chemiluminescence and magnetic separation[J]. Biomater Sci, 2017, 5(1): 57−66. doi: 10.1039/c6bm00527f
    Lelie N, Bruhn R, Busch M, et al. Detection of different categories of hepatitis B virus (HBV) infection in a multi-regional study comparing the clinical sensitivity of hepatitis B surface antigen and HBV-DNA testing[J]. Transfusion, 2017, 57(1): 24−35. doi: 10.1111/trf.13819
    Laperche S, Nübling CM, Stramer SL, et al. Sensitivity of hepatitis C virus core antigen and antibody combination assays in a global panel of window period samples[J]. Transfusion, 2015, 55(10): 2489−2498. doi: 10.1111/trf.13179
    Chacón L, Mateos ML, Holguín Á. Relevance of cutoff on a 4th generation ELISA performance in the false positive rate during HIV diagnostic in a low HIV prevalence setting[J]. J Clin Virol, 2017, 92: 11−13. doi: 10.1016/j.jcv.2017.04.014
    Hasanzadeh M, Shadjou N, de la Guardia M. Iron and iron-oxide magnetic nanoparticles as signal-amplification elements in electrochemical biosensing[J]. TrAC-Trend Anal Chem, 2015, 72: 1−9. doi: 10.1016/j.trac.2015.03.016
    Wang J, Ali Z, Si J, et al. Simultaneous extraction of DNA and RNA from hepatocellular carcinoma (Hep G2) based on silica-coated magnetic nanoparticles[J]. J Nanosci Nanotechnol, 2017, 17(1): 802−806. doi: 10.1166/jnn.2017.12442
    Li Z, Wang J, Yang H, et al. Ultrasensitive detection of gastric cancer plasma microRNAs via magnetic beads-based chemiluminescent assay[J]. J Biomed Nanotechnol, 2017, 13(10): 1272−1280. doi: 10.1166/jbn.2017.2426
    Zhu W, Zeng J, Li T, et al. Evaluation of the application of Chemiluminescence immunoassay(CLIA) in blood screening[J]. Chin J Blood Transfus (in Chinese), 2016, 29(6): 581−583. doi: 10.13303/j.cjbt.issn.1004-549x.2016.06.008
    Li L, Xing W. The application of chemiluminescence in the detection of HCV/HIV[J]. Chin J AIDS STD (in Chinese), 2011, 17(3): 382−385. doi: 10.13419/j.cnki.aids.2011.03.034
    Zhang YF, Quan X, Song GC, et al. Clinical effects of CD200 on the outcome of acute myeloid leukemia patients with diverse treatments[J]. Blood Genom, 2022, 6(2): 133−140. doi: 10.46701/BG.2021022022018
  • 加载中


    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(7)  / Tables(3)

    Article Metrics

    Article views (322) PDF downloads(9) Cited by()
    Proportional views


    DownLoad:  Full-Size Img  PowerPoint